相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。ZNF460 mediates epithelial-mesenchymal transition to promote gastric cancer progression by transactivating APOC1 expression
Liangliang An et al.
EXPERIMENTAL CELL RESEARCH (2023)
Levels of pretreatment serum lipids predict responses to PD-1 inhibitor treatment in advanced intrahepatic cholangiocarcinoma
Zhenyun Yang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2023)
BAL Proteomic Signature of Lung Adenocarcinoma in IPF Patients and Its Transposition in Serum Samples for Less Invasive Diagnostic Procedures
Lorenza Vantaggiato et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Carbohydrate, Lipid, and Apolipoprotein Biomarkers in Blood and Risk of Thyroid Cancer: Findings from the AMORIS Cohort
Xue Xiao et al.
Cancers (2023)
Elevated expression of ISY1, APOA-1, SYNE1, MTG1, and MMP10 at HCC initiation: HCC specific protein network involving interactions of key regulators of lipid metabolism, EGFR signaling, MAPK, and splicing pathways
Laila H. Faraj Shaglouf et al.
PROTOPLASMA (2023)
Apolipoprotein E induces pathogenic senescent-like myeloid cells in prostate cancer
Nicolo Bancaro et al.
CANCER CELL (2023)
Cholesterol efflux pathways hinder KRAS-driven lung tumor progenitor cell expansion
Emma Guilbaud et al.
CELL STEM CELL (2023)
Increased plasma lipids in triple-negative breast cancer and impairment in HDL functionality in advanced stages of tumors
Maria Isabela Bloise Alves Caldas Sawada et al.
SCIENTIFIC REPORTS (2023)
From degenerative disease to malignant tumors: Insight to the function of ApoE
Ganggang Miao et al.
BIOMEDICINE & PHARMACOTHERAPY (2023)
Involvement of clusterin expression in the refractory response of pancreatic cancer cells to a MEK inhibitor
Kohei Amada et al.
CANCER SCIENCE (2023)
Metabolic syndrome and thyroid Cancer: risk, prognosis, and mechanism
Ling-Rui Li et al.
DISCOVER ONCOLOGY (2023)
The role and function of CLU in cancer biology and therapy
Yefei Zhang et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2023)
Serum apolipoprotein B to apolipoprotein A-I ratio is an independent predictor of liver metastasis from locally advanced rectal cancer in patients receiving neoadjuvant chemoradiotherapy plus surgery
Chen Chen et al.
BMC CANCER (2022)
Noninvasive risk stratification of intraductal papillary mucinous neoplasia with malignant potential by serum apolipoprotein-A2-isoforms
Klaus Felix et al.
INTERNATIONAL JOURNAL OF CANCER (2022)
Integrated weighted gene co-expression network analysis reveals biomarkers associated with prognosis of high-grade serous ovarian cancer
Bo Wang et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2022)
FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner
Jiapeng Huang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)
Ferroptosis in cancer therapy: a novel approach to reversing drug resistance
Chen Zhang et al.
MOLECULAR CANCER (2022)
Inhibition of Lung Tumor Development in ApoE Knockout Mice via Enhancement of TREM-1 Dependent NK Cell Cytotoxicity (vol 10, 1379, 2019)
Yong Sun Lee et al.
FRONTIERS IN IMMUNOLOGY (2022)
Diagnostic performance of clusterin in hepatocellular carcinoma: A meta-analysis
Ge Gao et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2022)
Novel efficacious microRNA-30c analogs reduce apolipoprotein B secretion in human hepatoma and primary hepatocyte cells
Pradeep Kumar Yadav et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2022)
Chromosomally Unstable Gastric Cancers Overexpressing Claudin-6 Disclose Cross-Talk between HNF1A and HNF4A, and Upregulated Cholesterol Metabolism
Sanyog Dwivedi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Apolipoproteins: New players in cancers
Yingcheng He et al.
FRONTIERS IN PHARMACOLOGY (2022)
Aberrant APOBEC3C expression induces characteristic genomic instability in pancreatic ductal adenocarcinoma
Yunzhen Qian et al.
ONCOGENESIS (2022)
Assessing Metabolic Risk Factors for LVSI in Endometrial Cancer: A Cross-Sectional Study
Qiaoyan Lin et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2022)
Effect of Serum Lipid Profile on the Risk of Breast Cancer: Systematic Review and Meta-Analysis of 1,628,871 Women
Mehran Nouri et al.
JOURNAL OF CLINICAL MEDICINE (2022)
Apolipoprotein A-II, a Player in Multiple Processes and Diseases
Gabriela Florea et al.
BIOMEDICINES (2022)
Analysis of the Relationship between the Expression Level of TTR and APOH and Prognosis in Patients with Colorectal Cancer Metastasis Based on Bioinformatics
Ye Lu et al.
CONTRAST MEDIA & MOLECULAR IMAGING (2022)
Apolipoprotein E2 inhibits mitochondrial apoptosis in pancreatic cancer cells through ERK1/2/CREB/BCL-2 signaling
Hui Wang et al.
Hepatobiliary & Pancreatic Diseases International (2022)
BRCA mutational status shapes the stromal microenvironment of pancreatic cancer linking clusterin expression in cancer associated fibroblasts with HSF1 signaling
Lee Shaashua et al.
NATURE COMMUNICATIONS (2022)
Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing
Xiaopei Hao et al.
REDOX BIOLOGY (2022)
Dysregulation of HNF1B/Clusterin axis enhances disease progression in a highly aggressive subset of pancreatic cancer patients
Shouhui Yang et al.
CARCINOGENESIS (2022)
Multiple biomarkers are more accurate than a combination of carbohydrate antigen 125 and human epididymis protein 4 for ovarian cancer screening
Kyung Nam Kang et al.
OBSTETRICS & GYNECOLOGY SCIENCE (2022)
The Functional Role of Lipoproteins in Atherosclerosis: Novel Directions for Diagnosis and Targeting Therapy
Yongzheng Lu et al.
AGING AND DISEASE (2022)
APOE Is a Prognostic Biomarker and Correlates with Immune Infiltrates in Papillary Thyroid Carcinoma
Xu Lin et al.
JOURNAL OF CANCER (2022)
TRIM15 promotes the invasion and metastasis of pancreatic cancer cells by mediating APOA1 ubiquitination and degradation
Yan Sun et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2021)
Comprehensive Identification of Potential Crucial Genes and miRNA-mRNA Regulatory Networks in Papillary Thyroid Cancer
Ben-yu Nan et al.
BIOMED RESEARCH INTERNATIONAL (2021)
ApoPred: Identification of Apolipoproteins and Their Subfamilies With Multifarious Features
Ting Liu et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Serum Metabolic Profiling Analysis of Chronic Gastritis and Gastric Cancer by Untargeted Metabolomics
Lin Yu et al.
FRONTIERS IN ONCOLOGY (2021)
Down-regulation of RBP4 indicates a poor prognosis and correlates with immune cell infiltration in hepatocellular carcinoma
Mingxing Li et al.
BIOSCIENCE REPORTS (2021)
Apolipoprotein A1 is negatively associated with male papillary thyroid cancer patients: a cross-sectional study of single academic center in China
Maoguang Ma et al.
BMC ENDOCRINE DISORDERS (2021)
Construction of a novel mRNA-miRNA-lncRNA network and identification of potential regulatory axis associated with prognosis in colorectal cancer liver metastases
Chen Lu et al.
AGING-US (2021)
Apolipoprotein E Promotes Immune Suppression in Pancreatic Cancer through NF-κB-Mediated Production of CXCL1
Samantha B. Kemp et al.
CANCER RESEARCH (2021)
A Five-Gene Prognostic Nomogram Predicting Disease-Free Survival of Differentiated Thyroid Cancer
Pan Ruchong et al.
DISEASE MARKERS (2021)
Ellagic Acid Suppresses ApoB Secretion and Enhances ApoA-1 Secretion from Human Hepatoma Cells, HepG2
Ayana Ieda et al.
MOLECULES (2021)
Apolipoprotein mimetics in cancer
Samuel C. Delk et al.
SEMINARS IN CANCER BIOLOGY (2021)
Oncogene APOL1 promotes proliferation and inhibits apoptosis via activating NOTCH1 signaling pathway in pancreatic cancer
Jiewei Lin et al.
CELL DEATH & DISEASE (2021)
The expression of FLNA and CLU in PBMCs as a novel screening marker for hepatocellular carcinoma
Rathasapa Patarat et al.
SCIENTIFIC REPORTS (2021)
Apolipoprotein C-II induces EMT to promote gastric cancer peritoneal metastasis via PI3K/AKT/mTOR pathway
Chao Wang et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2021)
Prognostic Value of Serum Apolipoprotein B to Apolipoprotein A-I Ratio in Hepatocellular Carcinoma Patients Treated with Transcatheter Arterial Chemoembolization: A Propensity Score-Matched Analysis
Meng-Meng Liu et al.
ONCOLOGY RESEARCH AND TREATMENT (2021)
Identifying the role of apolipoprotein A-I in prostate cancer
Jing Wang et al.
ASIAN JOURNAL OF ANDROLOGY (2021)
Identification of Novel Biomarkers Associated With the Prognosis and Potential Pathogenesis of Breast Cancer via Integrated Bioinformatics Analysis
Meng Wu et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2021)
Serum lipid profiles and risk of colorectal cancer: a prospective cohort study in the UK Biobank
Zhe Fang et al.
BRITISH JOURNAL OF CANCER (2021)
Secretory clusterin promotes hepatocellular carcinoma progression by facilitating cancer stem cell properties via AKT/GSK-3β/β-catenin axis
Wenjie Zheng et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
Revelation of Proteomic Indicators for Colorectal Cancer in Initial Stages of Development
Arthur T. Kopylov et al.
MOLECULES (2020)
A dual apolipoprotein C-II mimetic-apolipoprotein C-III antagonist peptide lowers plasma triglycerides
Anna Wolska et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Apolipoprotein E2 modulates cell cycle function to promote proliferation in pancreatic cancer cells via regulation of the c-Myc-p21Waf1 signalling pathway
Shaoxia Du et al.
BIOCHEMISTRY AND CELL BIOLOGY (2020)
APOB Genotypes and CDH13 Haplotypes in the Cholesterol-Related Pathway Genes Predict Non-Small Cell Lung Cancer Survival
Wei Deng et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2020)
Apolipoproteins, as the carrier proteins for lipids, are involved in the development of breast cancer
Y. Zhou et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2020)
Apolipoprotein A-I Mimetic Peptide L-4F Suppresses Granulocytic-Myeloid-Derived Suppressor Cells in Mouse Pancreatic Cancer
Meiyu Peng et al.
FRONTIERS IN PHARMACOLOGY (2020)
Apolipoprotein: prospective biomarkers in digestive tract cancer
Yibo Zhang et al.
Translational Cancer Research (2020)
Neuronal Calcium Sensor 1 is up-regulated in response to stress to promote cell survival and motility in cancer cells
Henrike K. Grosshans et al.
MOLECULAR ONCOLOGY (2020)
Identification of key genes of papillary thyroid carcinoma by integrated bioinformatics analysis
Gang Xue et al.
BIOSCIENCE REPORTS (2020)
Novel circulating protein biomarkers for thyroid cancer determined through data-independent acquisition mass spectrometry
Dandan Li et al.
PEERJ (2020)
Systemic Proteome Alterations Linked to Early Stage Pancreatic Cancer in Diabetic Patients
Hong Peng et al.
CANCERS (2020)
Diagnostic value of clusterin immunostaining in hepatocellular carcinoma
Yuan Li et al.
DIAGNOSTIC PATHOLOGY (2020)
Low high-density lipoprotein and increased risk of several cancers: 2 population-based cohort studies including 116,728 individuals
Kasper Monsted Pedersen et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Clusterin contributes to hepatitis C virus-related hepatocellular carcinoma by regulating autophagy
Na Fu et al.
LIFE SCIENCES (2020)
Plasma proteome atlas for differentiating tumor stage and post-surgical prognosis of hepatocellular carcinoma and cholangiocarcinoma
Ting-Tsung Chang et al.
PLOS ONE (2020)
Liver X Receptor β Related to Tumor Progression and Ribosome Gene Expression in Papillary Thyroid Cancer
Seonhyang Jeong et al.
ENDOCRINOLOGY AND METABOLISM (2020)
Prognostic value of the serum apolipoprotein B to apolipoprotein A-I ratio in metastatic colorectal cancer patients
Dong-Dong Yang et al.
JOURNAL OF CANCER (2020)
Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging
Andrew Smith et al.
JOURNAL OF PROTEOMICS (2019)
Anti-tumorigenic and Platinum-Sensitizing Effects of Apolipoprotein A1 and Apolipoprotein A1 Mimetic Peptides in Ovarian Cancer
Aline T. Marinho et al.
FRONTIERS IN PHARMACOLOGY (2019)
Clinical Significance of Plasma Apolipoprotein-AII Isoforms as a Marker of Pancreatic Exocrine Disorder for Patients with Pancreatic Adenocarcinoma Undergoing Chemoradiotherapy, Paying Attention to Pancreatic Morphological Changes
Aoi Hayasaki et al.
BIOMED RESEARCH INTERNATIONAL (2019)
Apolipoprotein AI and B as risk factors for development of intraocular metastasis in patients with breast cancer
Jia-Xiang Liu et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Apolipoprotein C1 (APOC1) promotes tumor progression via MAPK signaling pathways in colorectal cancer
Hui Ren et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Diagnostic and prognostic significance of mRNA expressions of apolipoprotein A and C family genes in hepatitis B virus-related hepatocellular carcinoma
Xiangkun Wang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Oxidative stress in lung cancer patients is associated with altered serum markers of lipid metabolism
Katarzyna Zablocka-Slowinska et al.
PLOS ONE (2019)
Cholesterol and 27-hydroxycholesterol promote thyroid carcinoma aggressiveness
Giovanna Revilla et al.
SCIENTIFIC REPORTS (2019)
Apolipoprotein C1 (APOC1) as a novel diagnostic and prognostic biomarker for gastric cancer
Jie Yi et al.
ANNALS OF TRANSLATIONAL MEDICINE (2019)
Neuronal calcium sensor 1 (NCS1) promotes motility and metastatic spread of breast cancer cells in vitro and in vivo
Jonathan E. Apasu et al.
FASEB JOURNAL (2019)
Alterations in the gut microbiota and metabolite profiles of thyroid carcinoma patients
Jing Feng et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Functions of N6-methyladenosine and its role in cancer
Liuer He et al.
MOLECULAR CANCER (2019)
Apolipoprotein C-II Mimetic Peptide Promotes the Plasma Clearance of Triglyceride-Rich Lipid Emulsion and the Incorporation of Fatty Acids into Peripheral Tissues of Mice
Tomohiro Komatsu et al.
JOURNAL OF NUTRITION AND METABOLISM (2019)
Serum proteome mapping of EGF transgenic mice reveal mechanistic biomarkers of lung cancer precursor lesions with clinical significance for human adenocarcinomas
Juergen Borlak et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
LXR/ApoE Activation Restricts Innate Immune Suppression in Cancer
Masoud F. Tavazoie et al.
CELL (2018)
Apolipoprotein C1 promotes prostate cancer cell proliferation in vitro
Wei-peng Su et al.
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2018)
Dipeptidyl peptidase 4 inhibitor anagliptin ameliorates hypercholesterolemia in hypercholesterolemic mice through inhibition of intestinal cholesterol transport
Moritaka Goto et al.
JOURNAL OF DIABETES INVESTIGATION (2018)
Treating the Intestine with Oral ApoA-I Mimetic Tg6F Reduces Tumor Burden in Mouse Models of Metastatic Lung Cancer
Arnab Chattopadhyay et al.
SCIENTIFIC REPORTS (2018)
Identification of serum proteins AHSG, FGA and APOA-I as diagnostic biomarkers for gastric cancer
Feiyu Shi et al.
CLINICAL PROTEOMICS (2018)
Association between thyroid function and lipid profiles, apolipoproteins, and high-density lipoprotein function
Kyong Yeun Jung et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2017)
Apolipoprotein A-I mimetic peptide 4F suppresses tumor-associated macrophages and pancreatic cancer progression
Meiyu Peng et al.
ONCOTARGET (2017)
Apolipoprotein C-II: New findings related to genetics, biochemistry, and role in triglyceride metabolism
Anna Wolska et al.
ATHEROSCLEROSIS (2017)
Glucose and lipoprotein biomarkers and breast cancer severity using data from the Swedish AMORIS cohort
Jennifer C. Melvin et al.
BMC CANCER (2017)
ApoE deficiency promotes colon inflammation and enhances the inflammatory potential of oxidized-LDL and TNF-α in primary colon epithelial cells
Ali H. El-Bahrawy et al.
BIOSCIENCE REPORTS (2016)
Diagnostic and prognostic significance of serum apolipoprotein C-I in triple-negative breast cancer based on mass spectrometry
Dongjian Song et al.
CANCER BIOLOGY & THERAPY (2016)
Apolipoproteins, lipids and risk of cancer
Signe Borgquist et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
ApolipoproteinL1 is expressed in papillary thyroid carcinomas
Mounia Chidiac et al.
PATHOLOGY RESEARCH AND PRACTICE (2016)
Apolipoproteins as Differentiating and Predictive Markers for Assessing Clinical Outcomes in Patients with Small Cell Lung Cancer
Jian Shi et al.
YONSEI MEDICAL JOURNAL (2016)
ApoA-I mimetic administration, but not increased apoA-I-containing HDL, inhibits tumour growth in a mouse model of inherited breast cancer
Lidia Cedo et al.
SCIENTIFIC REPORTS (2016)
High-density Lipoproteins and Apolipoprotein A-I: Potential New Players in the Prevention and Treatment of Lung Disease
Elizabeth M. Gordon et al.
FRONTIERS IN PHARMACOLOGY (2016)
Tissue and serum samples of patients with papillary thyroid cancer with and without benign background demonstrate different altered expression of proteins
Mardiaty Iryani Abdullah et al.
PEERJ (2016)
Creation of Apolipoprotein C-II (ApoC-II) Mutant Mice and Correction of Their Hypertriglyceridemia with an ApoC-II Mimetic Peptides
Toshihiro Sakurai et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
Apolipoprotein A-I: A Molecule of Diverse Function
Manaswini Mangaraj et al.
INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY (2016)
Prospective associations between serum biomarkers of lipid metabolism and overall, breast and prostate cancer risk
Mathilde His et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2014)
Absolute quantification of apolipoproteins and associated proteins on human plasma lipoproteins
Anne von Zychlinski et al.
JOURNAL OF PROTEOMICS (2014)
Discovery of serum biomarkers of ovarian cancer using complementary proteomic profiling strategies
John F. Timms et al.
PROTEOMICS CLINICAL APPLICATIONS (2014)
Clusterin: a key player in cancer chemoresistance and its inhibition
Tomas Koltai
ONCOTARGETS AND THERAPY (2014)
Apolipoprotein L2 contains a BH3-like domain but it does not behave as a BH3-only protein
J. Galindo-Moreno et al.
CELL DEATH & DISEASE (2014)
Apolipoprotein E genetic polymorphism, serum lipoprotein levels and breast cancer risk: A case-control study
Gabriela Herrmann Cibeira et al.
MOLECULAR AND CLINICAL ONCOLOGY (2014)
Novel serum protein biomarker panel revealed by mass spectrometry and its prognostic value in breast cancer
Liping Chung et al.
BREAST CANCER RESEARCH (2014)
Association Between Urinary Albumin Excretion and Low-density Lipoprotein Heterogeneity Following Treatment of Type 2 Diabetes Patients with the Dipeptidyl Peptidase-4 Inhibitor, Vildagliptin: A Pilot Study
Shigemasa Tani et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2013)
Apolipoprotein Concentrations Are Elevated in Malignant Ovarian Cyst Fluids Suggesting That Lipoprotein Metabolism Is Dysregulated in Epithelial Ovarian Cancer
Iwona Podzielinski et al.
CANCER INVESTIGATION (2013)
Hooked on fat: the role of lipid synthesis in cancer metabolism and tumour development
Franziska Baenke et al.
DISEASE MODELS & MECHANISMS (2013)
Apolipoprotein C-II Is a Potential Serum Biomarker as a Prognostic Factor of Locally Advanced Cervical Cancer After Chemoradiation Therapy
Yoko Harima et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
The Cardioprotective Protein Apolipoprotein A1 Promotes Potent Anti-tumorigenic Effects
Maryam Zamanian-Daryoush et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
An apolipoprotein A-I mimetic targets scavenger receptor A on tumor-associated macrophages: A prospective anticancer treatment?
Claudine Neyen et al.
ONCOIMMUNOLOGY (2013)
Novel Biological Functions of High-Density Lipoprotein Cholesterol
Chieko Mineo et al.
CIRCULATION RESEARCH (2012)
Proteomic identification of serum biomarkers for gastric cancer using multi-dimensional liquid chromatography and 2D differential gel electrophoresis
Wentao Liu et al.
CLINICA CHIMICA ACTA (2012)
Human apolipoprotein L1 (ApoL1) in cancer and chronic kidney disease
Chien-An A. Hu et al.
FEBS LETTERS (2012)
D-4F, an apoA-I mimetic peptide, inhibits proliferation and tumorigenicity of epithelial ovarian cancer cells by upregulating the antioxidant enzyme MnSOD
Ekambaram Ganapathy et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Search for Breast Cancer Biomarkers in Fractionated Serum Samples by Protein Profiling With SELDI-TOF MS
Annemieke W. J. Opstal-van Winden et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2012)
Stable Knockdown of Clusterin by Vector-based RNA Interference in a Human Breast Cancer Cell Line Inhibits Tumour Cell Invasion and Metastasis
J. Li et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2012)
Multiplexed bead-based immunoassay of four serum biomarkers for diagnosis of ovarian cancer
Yong-Wan Kim et al.
ONCOLOGY REPORTS (2012)
Screening and identification of serum proteomic biomarkers for gastric adenocarcinoma
Chibo Liu et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2012)
Apolipoprotein E (APOE) Polymorphisms and Susceptibility to Breast Cancer: A Meta-Analysis
Mostafa Saadat
CANCER RESEARCH AND TREATMENT (2012)
Apolipoprotein A-I Mimetic Peptides Inhibit Expression and Activity of Hypoxia-Inducible Factor-1α in Human Ovarian Cancer Cell Lines and a Mouse Ovarian Cancer Model
Feng Gao et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Proteomic biomarkers apolipoprotein A1, truncated transthyretin and connective tissue activating protein III enhance the sensitivity of CA125 for detecting early stage epithelial ovarian cancer
Charlotte H. Clarke et al.
GYNECOLOGIC ONCOLOGY (2011)
L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways
Feng Gao et al.
INTEGRATIVE BIOLOGY (2011)
A Novel Anti-Apoptotic Role for Apolipoprotein L2 in IFN-γ-Induced Cytotoxicity in Human Bronchial Epithelial Cells
Wupeng Liao et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2011)
Apolipoprotein A1 -75 G/A and +83 C/T polymorphisms: susceptibility and prognostic implications in breast cancer
Bechr Hamrita et al.
MOLECULAR BIOLOGY REPORTS (2011)
Apolipoprotein E expression promotes lung adenocarcinoma proliferation and migration and as a potential survival marker in lung cancer
Wen-Pin Su et al.
LUNG CANCER (2011)
A Novel Peptide Derived from Human Apolipoprotein E Is an Inhibitor of Tumor Growth and Ocular Angiogenesis
Partha S. Bhattacharjee et al.
PLOS ONE (2011)
Serum Apolipoproteins C-I and C-III Are Reduced in Stomach Cancer Patients: Results from MALDI-Based Peptidome and Immuno-Based Clinical Assays
Meital Cohen et al.
PLOS ONE (2011)
Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M
Christina Christoffersen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Apolipoproteins: metabolic role and clinical biochemistry applications
Marek H. Dominiczak et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2011)
Plasmin-clipped β2-glycoprotein-I inhibits endothelial cell growth by down-regulating cyclin A, B and D1 and up-regulating p21 and p27
Wolf-Dietrich C. Beecken et al.
CANCER LETTERS (2010)
Family-based association analysis of 42 hereditary prostate cancer families identifies the Apolipoprotein L3 region on chromosome 22q12 as a risk locus
Bo Johanneson et al.
HUMAN MOLECULAR GENETICS (2010)
Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer
Feng Su et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The isolation and identification of apolipoprotein C-I in hormone-refractory prostate cancer using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry
Kaori Yamamoto-Ishikawa et al.
ASIAN JOURNAL OF ANDROLOGY (2009)
Overexpression of Clusterin in Ovarian Cancer is Correlated With Impaired Survival
Guofen F. Yang et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2009)
Discovery and identification of potential biomarkers of papillary thyroid carcinoma
Yuxia Fan et al.
MOLECULAR CANCER (2009)
Increased apolipoprotein E gene expression and protein concentration in lung cancer tissue do not contribute to the clinical assessment of non-small cell lung cancer patients
Zoran Trost et al.
ARCHIVES OF MEDICAL RESEARCH (2008)
Multiple actions of high-density lipoprotein
Matilda Florentin et al.
CURRENT OPINION IN CARDIOLOGY (2008)
Microarray analysis of normal cervix, carcinoma in situ, and invasive cervical cancer: identification of candidate genes in pathogenesis of invasion in cervical cancer
J. Y. Song et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2008)
Influence of Apolipoprotein E Gene Polymorphism on the Risk for Breast Cancer
D. Surekha et al.
INTERNATIONAL JOURNAL OF HUMAN GENETICS (2008)
Fine-needle aspiration of thyroid nodules: Proteomic analysis to identify cancer biomarkers
Laura Giusti et al.
JOURNAL OF PROTEOME RESEARCH (2008)
2-D difference gel electrophoresis of the lung squamous cell carcinoma versus normal sera demonstrates consistent alterations in the levels of ten specific proteins
Paul Dowling et al.
ELECTROPHORESIS (2007)
HDL-c is a powerful lipid predictor of cardiovascular diseases
E. Bruckert et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2007)
Subendothelial lipoprotein retention as the initiating process in atherosclerosis -: Update and therapeutic implications
Ira Tabas et al.
CIRCULATION (2007)
Anticlusterin treatment of breast cancer cells increases the sensitivities of chemotherapy and tamoxifen and counteracts the inhibitory action of dexamethasone on chemotherapy-induced cytotoxicity
Maximino Redondo et al.
BREAST CANCER RESEARCH (2007)
Association between the apolipoprotein E genotypes and breast cancer patients in Taiwanese
Shun-Jen Chang et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Apolipoprotein E expression in anaplastic thyroid carcinoma
Yasuhiro Ito et al.
ONCOLOGY (2006)
Knockdown of the cytoprotective chaperone, clusterin, chemosensitizes human breast cancer cells both in vitro and in vivo
A So et al.
MOLECULAR CANCER THERAPEUTICS (2005)
Influences of apolipoprotein E polymorphism on the risk for breast cancer and HER2/neu status in Taiwan
NW Chang et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
Gene expression profile of gastric carcinoma: Identification of genes and tags potentially involved in invasion, metastasis, and carcinogenesis by serial analysis of gene expression
N Oue et al.
CANCER RESEARCH (2004)
Silencing expression of the clusterin/apolipoprotein J gene in human cancer cells using small interfering RNA induces spontaneous apoptosis, reduced growth ability, and cell sensitization to genotoxic and oxidative stress
IP Trougakos et al.
CANCER RESEARCH (2004)
Apolipoprotein-D: A novel cellular marker for HGPIN and prostate cancer
RE Hall et al.
PROSTATE (2004)
Activation of liver X receptors and retinoid X receptors prevents bacterial-induced macrophage apoptosis
AF Valledor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Association of NQOI polymorphism with spontaneous breast cancer in two independent populations
HJ Menzel et al.
BRITISH JOURNAL OF CANCER (2004)
The apolipoprotein E ε4 allele is not a risk factor for Turkish breast cancer patients
I Yaylim et al.
CANCER GENETICS AND CYTOGENETICS (2003)
The role of the high-density lipoprotein receptor SR-BI in the lipid metabolism of endocrine and other tissues
A Rigotti et al.
ENDOCRINE REVIEWS (2003)
L-4F, an apolipoprotein A-1 mimetic, restores nitric oxide and superoxide anion balance in low-density lipoprotein-treated endothelial cells
ZJ Ou et al.
CIRCULATION (2003)
Apolipoprotein D inhibits platelet-derived growth factor-BB-induced vascular smooth muscle cell proliferated by preventing translocation of phosphorylated extracellular signal regulated kinase 1/2 to the nucleus
JM Sarjeant et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Apolipoprotein E phenotype, cholesterol and breast and prostate cancer
M Niemi et al.
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH (2000)
Apolipoprotein D
E Rassart et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY (2000)
Apolipoprotein E polymorphism and breast carcinoma: correlation with cell proliferation indices and clinical outcome
E Zunarelli et al.
BREAST CANCER RESEARCH AND TREATMENT (2000)
Expression and clinical significance of apolipoprotein D in epithelial ovarian carcinomas
J Vazquez et al.
GYNECOLOGIC ONCOLOGY (2000)